| The obesity-MS connection | Emerging research on semaglutide and MS | How does Wegovy work
(PubMed) Further, in a myocardial infarction model in rats, semaglutide treatment reduced body-weight, bloodglucose and lipid levels, improved left ventricular ejection fraction, reduced myocardial fibrosis, and altered myocardial metabolism (via untargeted metabolomics) to reflect beneficial remodeling of amino sugar/nucleotide sugar, lipid and organic acid pathways
Although this type of vision loss is a rare side effect, patients should talk to their doctors about monitoring for signs of the condition
The caveat that matters in TRIUMPH-3 A secondary analysis found no statistically significant reduction in major cardiovascular events compared with placebo
It stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it only promotes insulin release when blood sugar levels are elevated